Filing Flows

Filing Flows › Merck (MRK) › Q1 2025

Merck (MRK) Q1 2025 earnings results (first quarter 2025)

10-Q filed May 2, 2025

Merck (MRK) reported revenue of $15.5B for the first quarter 2025 (Q1 2025), -2% from a year earlier and -0.6% from the quarter before. Operating margin was 38.0%, net earnings $5.1B (32.7% of revenue).

Revenue$15.5B
Year over year-2%
Quarter over quarter-0.6%
Operating margin38.0%
Net earnings$5.1B

Merck, Q1 2025: revenue $15.5B (-2% year over year), operating margin 38.0%, net earnings $5.1B, operating cash flow $2.5B. The chart follows the revenue to costs, profit and cash.

Q1 2025AmountQ/QY/Y
Revenue$15.5B-0.6%-2%
Operating profit$5.9B+42%+4%
Net earnings$5.1B+36%+7%
Operating cash flow$2.5B-28%-19%
Free cash flow$1.2B-53%-47%

What changed

Revenue was $15.5B in Q1 2025, down 2% year over year and down 1% from the previous quarter.

Operating profit was $5.9B, a 38.0% margin (up 2.1 points year over year). Total costs fell 5% while revenue fell 2%. Net earnings were $5.1B, up 7% year over year. The effective tax rate was 13.9%.

Operating cash flow was $2.5B (down 19% year over year), 49% of net earnings. Non-cash charges added back $0.50B of depreciation and $0.20B of share-based compensation. Working capital and other items used $3.3B. Capital expenditures of $1.3B left free cash flow of $1.2B.

Questions

What was Merck's revenue in the first quarter 2025?

Merck (MRK) reported revenue of $15.5B for the first quarter 2025 (Q1 2025), -2% from a year earlier and -0.6% from the quarter before.

Was Merck profitable in the first quarter 2025?

Operating profit was $5.9B (38.0% of revenue) and net earnings $5.1B.

Open the interactive Sankey →

Source: Merck 10-Q on SEC EDGAR.